Eli Lilly and Co
NYSE:LLY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Eli Lilly and Co
NYSE:LLY
|
US |
|
Ricegrowers Ltd
ASX:SGLLV
|
AU |
|
H
|
Hikari Business Form Co Ltd
TSE:3948
|
JP |
|
Bank First Corp
NASDAQ:BFC
|
US |
|
Suedwestdeutsche Salzwerke AG
F:SSH
|
DE |
|
G
|
Gamer Pakistan Inc
NASDAQ:GPAK
|
US |
Wall Street
Price Targets
LLY Price Targets Summary
Eli Lilly and Co
According to Wall Street analysts, the average 1-year price target for
LLY
is 1 226.97 USD
with a low forecast of 838.3 USD and a high forecast of 1 575 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is LLY's stock price target?
Price Target
1 226.97
USD
According to Wall Street analysts, the average 1-year price target for
LLY
is 1 226.97 USD
with a low forecast of 838.3 USD and a high forecast of 1 575 USD.
What is Eli Lilly and Co's Revenue forecast?
Projected CAGR
19%
For the last 14 years the
compound annual growth rate for
Eli Lilly and Co's revenue is
7%.
The projected
CAGR
for the next 3 years is
19%.
What is Eli Lilly and Co's Operating Income forecast?
Projected CAGR
22%
For the last 14 years the
compound annual growth rate for
Eli Lilly and Co's operating income is
12%.
The projected
CAGR
for the next 3 years is
22%.
What is Eli Lilly and Co's Net Income forecast?
Projected CAGR
32%
For the last 14 years the
compound annual growth rate for
Eli Lilly and Co's net income is
12%.
The projected
CAGR
for the next 3 years is
32%.
